A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine

Clinical trial NCT01675284 · COMPLETED

Trial details

NCT number: NCT01675284
Sponsor: Medigen Biotechnology Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bird Flu Avian Influenza Influenza A(H5N1)

Start date: 2012-08-01
Primary completion: 2013-03-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.